DMED

EURONEXT:DMED

Diagnamed Holdings Corp.

  • Stock

Last Close

0.01

25/09 14:21

Market Cap

1.60M

Beta: -

Volume Today

4.50K

Avg: 288.30K

PE Ratio

−2.85

PFCF: −3.95

  • market

    STOCKS
  • ipo date

    Nov 08, 2022

Diagnamed Holdings Corp. engages in developing a platform of software-based prescription digital therapeutic products for detecting brain age and tremors for neurological disorders. The company is headquartered in Vancouver, Canada.

Earnings

Earnings per Share (Estimate*)

-0.0050.0050.012021-12-312022-03-312022-12-312023-03-31

Revenue (Estimate*)

0.000.000.010.010.012021-12-312022-03-312022-12-312023-03-31

*Estimate based on analyst consensus